October 7, 2020
How US tax reform is testing the life sciences sector
Life sciences companies thought they were busy enough dealing with the digital revolution while their tax departments coped with e-filings and even e-audits. But new this year, they have been confronted by a corporate tax revolution in the US. Recent US tax reform raises significant issues for life sciences firms and their tax advisors. An EY article provides details.